WebMay 24, 2024 · Non-GAAP (2) net income of $340 million with EPS of $1.13, up 16% from the second quarter of 2024. Full-year revenue is expected to be in the range of $6.67 billion to $6.73 billion, representing reported growth of 5.6% to 6.5% and increased core (1) growth to a range of 8% to 9%. WebFeb 15, 2024 · Cryoport to Report Fourth Quarter and Full Year 2024 Financial Results on February 23, 2024
Cryoport to Report Fourth Quarter and Full Year 2024 Financial …
WebFeb 15, 2024 · NASHVILLE, Tenn., Feb. 15, 2024 /PRNewswire/ -- Cryoport, Inc. (Nasdaq: CYRX) ("Cryoport" or the "Company"), a global leader in temperature-controlled supply chain solutions for the life sciences industry, today announced that the Company will report financial results for the fourth quarter and year ended December 31, 2024 on Thursday, … WebApr 10, 2024 · Cryoport also has a robust pipeline of clients developing C> treatments, supporting a total of 654 active trials. Of these, 275 (or 42%) are in Phase 1, 300 (46%) are in Phase 2, and 79 (12% ... thi plan
CryoPort, Inc. Common Stock (CYRX) Earnings Report …
WebNov 3, 2024 · Third quarter revenue of $60.5 million; nine months 2024 revenue reaches $176.9 million; Cryoport Systems' revenue up 25% year-over-year $530 million in cash and short-term investments Supporting... WebFeb 23, 2024 · Cryoport delivered a solid finish to 2024 with total revenue of $237.3 million, led by a 24% revenue increase from Cryoport Systems and driven by the demand for … WebApr 10, 2024 · Cryoport issued an update on its FY 2024 earnings guidance on Thursday, February, 23rd. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $270.00 million-$290.00 million, compared to the consensus revenue estimate of $262.75 million. thi primuss stundenplan